Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹46.5 Cr -9.7% -37.3% -55.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,991.4 Cr -5.9% -14.2% -21.1% Stock Analytics
KIRI INDUSTRIES ₹2,103.2 Cr -6.6% -23.3% -38.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,325.8 Cr -5% -11.5% -38.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,002.2 Cr 3.7% 0.9% 7% Stock Analytics
BODAL CHEMICALS ₹719.3 Cr 5% 20.8% -10.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-9.7%

-37.3%

-55.6%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses